HESTERBIO
NSEHester Biosciences Limited (SMALL CAP)
Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹2,120.90
18.70 (0.89%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹1.80K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
35.0
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹1,239.3+71.1%
52W High₹2,350-9.7%
Current Price
₹2,120.90
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹1,696.72
Upper Circuit₹2,545.08
Reference Price
₹2,120.90
Investment Checklist
Double Bottom on 1D (BREAKOUT CONFIRMED) — target ₹2369.0
Double Top on 1D — target ₹1822.4
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Composite score 36.85 (BUY) with 83.9% confidence
EMA(20) Crossover: Price crossed above EMA(20): Fresh bullish momentum signal.
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
84%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
2111.76
EMA50
1967
EMA200
1787.6
Price Action
MIXED
NEUTRAL
Higher Highs3
Higher Lows6
Lower Highs6
Lower Lows3
Support & Resistance Levels
Resistance (Above)
₹2176.00
₹2238.70
₹2315.00
₹2350.00
Support (Below)
₹2070.00
₹1990.00
₹1910.20
₹1878.20
₹1799.00
Volume Analysis
TrendDECREASING
Change-59.30%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹2099.69
3% Risk₹2057.27
5% Risk₹2014.86
7% Risk (Custom)
₹1972.44Technical Levels
1x ATR (Volatility)₹2027.39
2x ATR (Swing)₹1933.88
3x ATR (Trend)₹1840.37
Immediate Support₹2070.00
Moving Averages
EMA 20 (Medium-term)₹2111.76
EMA 50 (Trend)₹1967.00
EMA 200 (Long-term)₹1787.60
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹81.9 Cr | ₹84.1 Cr | ₹71 Cr | ₹77.4 Cr |
| Net Profit | ₹1.3 Cr | ₹16.4 Cr | ₹14.4 Cr | ₹8.8 Cr |
| EPS | — | ₹20.33 | ₹16.85 | ₹10.94 |
| Operating Profit | ₹9.2 Cr | ₹26.2 Cr | ₹23.6 Cr | ₹19.8 Cr |
ROE
8.75%
ROCE
9.08%
Debt/Equity
0.68
Current Ratio
1.56
OPM
25.55%
NPM
11.32%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Hester Biosciences Limited | ₹2,120.90 | +0.89% | 35.0 | ₹1.80K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 06 Aug 2025 | Dividend - Rs 7 Per Share | DIVIDEND |
| 22 Aug 2024 | Dividend - Rs 6 Per Share | DIVIDEND |
| 22 Aug 2024 | Annual General Meeting | AGM |
| 13 Sept 2023 | Annual General Meeting/Dividend - Rs 8 Per Share | AGM |
| 11 Aug 2022 | Annual General Meeting/Dividend - Rs 10 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for HESTERBIO
View AllNEWS
positive
Business Standard - Markets 56d ago
Hester Biosciences consolidated net profit rises 1138.76% in the March 2026 quarter
Sales rise 22.19% to Rs 100.11 crore
HESTERBIOHealthcare
NEWS
neutral
Business Standard - Markets 57d ago
Noida Toll Bridge Company Ltd leads gainers in 'B' group
Mahalaxmi Fabric Mills Ltd, NRB Industrial Bearings Ltd, Hester Biosciences Ltd and Hybrid Financial Services Ltd are among the other gainers in the BSE's 'B' group today, 15 May 2026.
BSEHESTERBIOHYBRIDFINJMFINANCILMFMLNIBLNOIDATOLLCapital GoodsFinancial Services
positive
CNBC TV18 - Markets 57d ago
Hester Biosciences Q4 Results: Stock jumps 14% after profit growth, strong operating performance
Hester Biosciences' board has recommended a dividend of ₹11 per equity share for FY26, subject to shareholder approval at the upcoming annual general meeting.
ARSSBLDIVIDENDHESTERBIOFinancial ServicesHealthcare